As of April 14, 2013, the National Health and Family Planning Commission notified the World Health Organization (WHO) of an additional two laboratory-confirmed cases of human infection with influenza A(H7N9) virus from Henan in China. The first patient is a 34-year-old man who became ill on April 6, 2013, and the second patient is a 65-year-old man who became ill on April 8, 2013. To date, a total of 51 patients have been laboratory-confirmed with influenza A(H7N9) virus in China; including 11 deaths. More than 1,000 close contacts of the confirmed cases are being closely monitored.
Investigations into the possible sources of infection and reservoirs of the virus are ongoing. Until the source of infection has been identified, it is expected that there will be further cases of human infection with the virus in China. So far, there is no evidence of ongoing human-to-human transmission.
The WHO does not advise special screening at points of entry with regard to this event, nor does it recommend that any travel or trade restrictions be applied.
To date, there is limited information to determine whether the reported number of cases represents some or all of the cases actually occurring. As some relatively mild cases of illness have now been reported, it is possible that there are other such cases that have not been identified and reported.
On April 1, 2013, the WHO first reported three human infections with a new influenza A (H7N9) virus in China. Since then, additional cases have been reported. Most reported cases have severe respiratory illness and, in some cases, have died. At this time, no cases of H7N9 outside of China have been reported. The new H7N9 virus has not been detected in people or birds in the United States.
This new H7N9 virus is an avian (bird) influenza (flu) virus. Human infections with avian influenza (AI, or bird flu) are rare but have occurred in the past, most commonly after exposure to infected poultry. However, this is the first time that this bird flu subtype (H7N9) has been found in people. This virus is very different from other H7N9 viruses previously found in birds.
An investigation by Chinese authorities is ongoing. H7N9 viruses have been detected in poultry in the same area where human infections have occurred. Many of the human cases of H7N9 are reported to have had contact with poultry. However, some cases reportedly have not had such contact. Close contacts of confirmed H7N9 patients are being followed to see if any human-to-human spread of H7N9 might have occurred. Based on previous experience with other avian influenza viruses most notably H5N1 some limited human-to-human spread of this H7N9 virus would not be surprising. Most importantly, however, no sustained person-to-person spread of the H7N9 virus has been found at this time. Ongoing (sustained) person-to-person spread is necessary for a pandemic to occur.
This is a novel (non-human) virus and therefore has the potential to cause a pandemic if it were to change to become easily and sustainably spread from person-to-person. So far, this virus has not been determined to have that capability. However, influenza viruses constantly change and its possible that this virus could gain that ability. The Centers for Disease Control and Prevention (CDC) takes routine preparedness actions whenever a new virus with pandemic potential is identified, including developing a candidate vaccine virus to make a vaccine if it were to be needed. There is no licensed H7 vaccine available at this time.
The CDC is following this situation closely and coordinating with domestic and international partners. In addition, the CDC has issued guidance to U.S. clinicians and public health departments on how to test for this virus, and interim guidance on case definitions for possible H7N9 cases in the United States and interim infection control guidance for U.S. healthcare workers. The CDC also has developed information for travelers to China.
I Was There: An Infection Preventionist on the COVID-19 Pandemic
April 30th 2025Deep feelings run strong about the COVID-19 pandemic, and some beautiful art has come out of those emotions. Infection Control Today is proud to share this poem by Carmen Duke, MPH, CIC, in response to a recent article by Heather Stoltzfus, MPH, RN, CIC.
From the Derby to the Decontam Room: Leadership Lessons for Sterile Processing
April 27th 2025Elizabeth (Betty) Casey, MSN, RN, CNOR, CRCST, CHL, is the SVP of Operations and Chief Nursing Officer at Surgical Solutions in Overland, Kansas. This SPD leader reframes preparation, unpredictability, and teamwork by comparing surgical services to the Kentucky Derby to reenergize sterile processing professionals and inspire systemic change.
Show, Tell, Teach: Elevating EVS Training Through Cognitive Science and Performance Coaching
April 25th 2025Training EVS workers for hygiene excellence demands more than manuals—it requires active engagement, motor skills coaching, and teach-back techniques to reduce HAIs and improve patient outcomes.
The Rise of Disposable Products in Health Care Cleaning and Linens
April 25th 2025Health care-associated infections are driving a shift toward disposable microfiber cloths, mop pads, and curtains—offering infection prevention, regulatory compliance, and operational efficiency in one-time-use solutions.